Pemivibart
Based on 1 Customer Validation
Pemivibart is an anti-SARS-CoV-2 human IgG1 λ2 monoclonal antibody. Recommend Isotype Controls: Human IgG1 lambda2, Isotype Control (HY-P990096).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.12%
- CAS No.: 2858673-18-2
- Masse moléculaire:144.788 kDa
-
Stockage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Isotype
Human IgG1 lambda2
Recommend Isotype Controls
Species Reactivity
Virus
IC50 & Target
SARS-CoV-2
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Gene ID
Accession
YP_009724390.1
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Human IgG1 lambda2
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Loaded Pemivibart on AHC2 biosensor, can bind SARS-CoV-2 S Protein RBD (sf9, His, HY-P73664) with an affinity constant of 4.334E-09 M as determined in BLI assay. -
Immobilized SARS-CoV-2 S Protein RBD (sf9, His, HY-P73664) can bind Pemivibart. The EC50 for this effect is 2.165 ng/mL.
Chemical Information
-
CAS No. 2858673-18-2
-
Appearance Liquid
-
Masse moléculaire 144.788 kDa
-
Color Colorless to light yellow
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (253 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
[1]. Pemivibart
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)